Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 2 1

Status

Recruiting 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 47Thoracic 6Genitourinary 5Head & Neck 3Gynecologic 3Dermatologic 2Breast 2Other solid neoplasm 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 285Head and Neck Neoplasms 250Carcinoma, Non-Small-Cell Lung 95Thyroid Neoplasms 92Melanoma 68Mouth Neoplasms 67Nasopharyngeal Carcinoma 64Oropharyngeal Neoplasms 63Breast Neoplasms 54Colorectal Neoplasms 49Lung Neoplasms 47Ovarian Neoplasms 45Neoplasm Metastasis 45Neoplasms 41Uterine Cervical Neoplasms 39Carcinoma, Squamous Cell 39Carcinoma, Renal Cell 34Triple Negative Breast Neoplasms 31Stomach Neoplasms 31Laryngeal Neoplasms 31Endometrial Neoplasms 29Carcinoma 29Sarcoma 28Esophageal Neoplasms 28Pancreatic Neoplasms 27Salivary Gland Neoplasms 26Prostatic Neoplasms 25Thyroid Cancer, Papillary 23Urinary Bladder Neoplasms 22Hypopharyngeal Neoplasms 22

Interventions

pembrolizumab 2Rosiglitazone 1Nivolumab 1Metformin 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Adenocarcinoma Of Esophagus × Head & Neck × 90 days × Clear all
NCT04389632 2026-05-11

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

Seagen Inc.

Phase 1 Recruiting
1,006 enrolled
GastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT04114136 2026-04-24

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

University of Pittsburgh

Phase 2 Recruiting
72 enrolled
DermatologicGastrointestinalHead & Neck

Adenocarcinoma Of Esophagus, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hepatocellular, Melanoma

NCT07090499 2026-04-07

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Pfizer

Phase 1 Recruiting
310 enrolled
GastrointestinalGenitourinaryHead & NeckThoracic

Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell, Esophageal Neoplasms, Head and Neck Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡